Articles | December 9, 2025
Our latest short quarterly insight for sponsors of group health plans focuses on high-cost claims (HCCs) and strategies for managing them.
It covers:
The insight also includes a compliance reminder to stay on top of ACA amounts.
A growing number of conditions can exceed $1 million per patient annual treatment costs; particularly hemophilia A and B, as well as sickle cell disease, according to SHAPE, Segal’s claims data warehouse.
Some therapies cost over $3.5 million, including Hemgenix® and Lenmeldy®,as noted in the American Journal of Health-System Pharmacy.
High-cost conditions with $100,000+ paid annual claims account for less than 1% of all claimants but almost 30% of total medical and prescription drug claim expenses, based on data from SHAPE.
As healthcare costs continue to rise amid economic uncertainty, HCCs remain one of the most significant drivers of financial strain for health plans. These claims — often stemming from complex conditions, specialty drugs and prolonged hospitalizations — can account for a disproportionate share of total spending, challenging even the most robust risk-management strategies. In today’s environment of inflationary pressures, evolving care models and increasing demand for advanced therapies, mitigating the impact of these claims is no longer optional — it’s essential for sustainability.
This issue of Trends explores the top 10 strategies health plan sponsors can deploy to effectively manage HCC spending without compromising quality of care:
Get our handy summary charts, ACA Dollar Amounts and Percentages, which we updated in November 2025.
Contact your Segal consultant or get in touch with us.
Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate
Health, Compliance, Healthcare Industry, Higher Education, Public Sector, Multiemployer Plans, Architecture Engineering & Construction, Pharmaceutical, Corporate
Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate, Pharmaceutical
This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.
© 2025 by The Segal Group, Inc.Terms & Conditions Privacy Policy Style Guide California Residents Sitemap Disclosure of Compensation Required Notices